Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
about
VEGF targets the tumour cell.Modeling of hypo/hyperglycemia and their impact on breast cancer progression related molecules.Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway.Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer.sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungContrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtypeRole of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis.VEGFR2 inhibition by RNA interference affects cell proliferation, migration, invasion, and response to radiation in Calu-1 cells.Biologically inhibitory effects of VEGF siRNA on endometrial carcinoma cells.Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours.Anti-Angiogenic Drugs: Involvement in Cutaneous Side Effects and Wound-Healing Complication.Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression.Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K/AKT/MAPK signaling pathways.A computational framework for complex disease stratification from multiple large-scale datasets.
P2860
Q33573324-AE604723-D48B-4A03-B84A-CDD7AB304051Q34527040-6827376C-71C2-4BA7-9C32-3B2ECD10E44AQ35172301-2850E2F8-07A3-410A-9A04-D16F80F3CFD2Q35926931-4E5EB4DD-0B86-42C1-B685-80DCF7B3DA88Q35939630-3CC76A39-D0C3-4A32-BE7C-42302B32D80AQ36544702-371086A2-BC40-439F-8EA1-627A5D35EEF6Q36571442-107F22C7-289A-4061-B382-E4582871CA43Q37308766-6220FD72-4F62-4715-BE64-F11B7AA1AC35Q37710826-F9F4D2EF-BA54-47F0-BB2B-7B2A49337BA4Q38750618-6AA9B1C9-4D6F-43CC-8EF1-A582132D033FQ38828535-058B6EDF-560F-4F9B-9E6C-DE7F5EAA7FCDQ39447186-B2D6DEFB-DAB5-482A-80B0-ADCEAD4E0CDEQ42682714-D095C601-94F7-4B76-8F12-02F10E4C18D1Q42926957-B6127DBB-4411-4D55-B04F-EC421BC89057Q54379435-BB4FC0F7-9A41-457C-9DEF-B1B3FF86B29CQ54977976-7DFFDE0B-C85A-4D13-8F3D-A5E2565A1CD9Q55139050-42728F42-863B-49F5-A26F-C5D07911A601
P2860
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
@ast
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
@en
type
label
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
@ast
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
@en
prefLabel
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
@ast
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
@en
P2860
P1476
Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells
@en
P2093
P2860
P2888
P304
P356
10.1038/LABINVEST.2010.52
P577
2010-03-01T00:00:00Z
P5875
P6179
1046008260